pancreatitis and glp-1 PSCs GLP-1R: occurrence in normal pancreas, acute/chronic and effect of their activation by a GLP-1R agonist american diabetes association pancreatitis history
Description
[DOI] [Google Scholar] 249.Pancrazi R., van Rens T., Vukotic M
Note: There are also emerging alternatives to GLP-1 medications
However, head-to-head comparisons are limited, and individual patient responses vary considerably
So far, it remains unclear to what extent the benefits are due to improvements in risk factors or if there are other mechanisms involved
If approved for a compounded GLP-1 program, follow the prescribing clinician's and dispensing pharmacy's dosing instructions precisely, and contact your clinical provider if you have any questions before administering a dose
